About Us
Founded in 1995, Lawley Pharmaceuticals is a privately owned, Perth-based Australian company and a global leader in the research and development of transdermal androgen hormone therapies for both women and men.
In 2020, over two decades of dedication culminated in Australian regulatory approvals that marked global breakthroughs in androgen hormone treatment.
Our innovative androgen hormone therapy for women represents a world-first regulatory approval for managing hypoactive sexual desire dysfunction in postmenopausal women.
For men, our low-dose scrotal androgen hormone application offers a fast-absorbing, cost-effective solution with an enhanced safety profile—minimising third-party passive transfer and reducing treatment costs for patients and healthcare systems.
At Lawley, we believe in working with the body—not against it—by delivering androgen hormone therapies that are body-identical, effective, and trusted.
Latest News
Did you know there is an initial screening tool to assist in the assessment of Hypoactive Sexual Desire Dysfunction (HSDD)?
Low Sexual Desire is Common Sexual difficulties and concerns are common across a woman’s lifespan, increasing at midlife and beyond menopause. The DSDS (Decreased… Continue Reading →
What Is the Best Way to Approach a Sexual Dry Spell in a Relationship?
International Society For Sexual Medicine What Is the Best Way to Approach a Sexual Dry Spell in a Relationship?
What Is the Connection Between Heart Health and Sexual Health?
International Society For Sexual Medicine What Is the Connection Between Heart Health and Sexual Health?